A five-month WashU trial shows a ketogenic diet reduced liver fat by 67 percent compared to 45 percent on other diets, while all groups improved metabolism.
On August 27, 2026, Cell Metabolism published new findings regarding dietary patterns and fatty liver disease. Washington University School of Medicine researchers conducted a randomized clinical trial involving 55 adults. The participants all had obesity, prediabetes, and fatty liver disease. The five-month study evaluated how three different diets impacted metabolic function when calories were controlled.
The trial assigned participants to either a ketogenic, Mediterranean, or plant-forward dietary pattern. A low-carbohydrate and high-fat approach characterized the ketogenic diet. The plant-forward option utilized a high-carbohydrate and low-fat structure. The Mediterranean diet offered a more balanced macronutrient profile.
For years, I watched smart, capable people blame themselves when standard diet advice failed them. They would cut calories drastically, run themselves into the ground and inevitably regain the weight. It was heartbreaking to see. I realized we were treating a complex biological and psychological system like a simple math problem. That was the turning point when I knew we had to focus on metabolic health and habits rather than just restriction.
The WashU trial helps illustrate how different nutritional inputs influence our internal systems. Insulin resistance often drives the accumulation of excess liver fat. When liver fat increases, the body struggles to regulate blood sugar efficiently. This metabolic friction can eventually lead to prediabetes and further cardiovascular complications.
By severely restricting carbohydrates, a ketogenic diet forces the body to shift its primary fuel source. This physiological shift can lower blood glucose and reduce the immediate need for insulin. Researchers note that lower insulin levels can then help the liver process stored fat more effectively. However, a lower insulin measurement alone is not inherently proof of superior overall health.
Mainstream media outlets often simplify complex clinical outcomes into basic diet comparisons. Medical Daily reported on these findings with a heavy emphasis on the ketogenic results. Yet, the mainstream coverage frequently omits the highly controlled nature of the study. The researchers provided participants with 100 percent of their food.
Participants also attended weekly meetings with a study dietitian to support adherence. This level of intensive professional support rarely reflects what people can reproduce in ordinary life. A highly controlled feeding study demonstrates what happens under highly structured clinical conditions. It does not necessarily show how easy the diets are to follow during work, travel, or periods of stress.
Medical Daily states that outcomes were reported for 42 participants out of the 55 originally assigned. This attrition rate matters when evaluating long-term feasibility and dietary adherence. Medical Daily reported results for 42 of the 55 people originally assigned to the trial, while the WashU summary describes the randomized enrollment as 55 adults. The results do not prove that one rigid diet is universally required to heal the liver.
Achieving gradual weight loss through sustainable daily habits remains a highly effective strategy. The available data shows that losing roughly 10 percent of starting body weight improves metabolic health across multiple eating styles.
Calories were meticulously adjusted so that groups reached approximately the same weight-loss target. Across all three diets, participants lost about 10 percent of their starting body weight. First author Max Petersen described this moderate weight reduction as broadly beneficial for metabolically unhealthy individuals. Total weight reduction clearly influenced cellular responses independently of the assigned macronutrient ratios.
Muscle-cell insulin sensitivity improved by approximately 50 percent from baseline in all three groups. The researchers interpreted this consistent pattern as a significant biological indicator. They viewed it as evidence that the amount of weight lost was the primary driver here. The specific fat-and-carbohydrate ratio alone did not dictate the muscle-related improvements.
Senior investigator Samuel Klein noted that all three diets improved metabolic health through weight loss. This improvement occurred despite the nutritional plans having vastly different macronutrient compositions. His perspective supports a balanced interpretation of the trial data. Achieving meaningful, maintainable weight management remains central to protecting metabolic health over time.
While muscle improvements were uniform, liver outcomes differed more clearly by diet. Liver fat fell by an average of 67 percent in the ketogenic group. In contrast, the Mediterranean and plant-forward groups achieved a 45 percent reduction. All three dietary patterns successfully reduced liver fat through consistent nutritional changes.
Liver insulin sensitivity also improved across all three study groups. However, this improvement was two to three times greater with the ketogenic diet. An expert reaction reported by the Science Media Centre noted this distinct physiological response. The greater reduction in liver fat was accompanied by notably higher ketone levels.
These specific liver responses suggest a shift in the body’s primary fuel use. The trial demonstrated that a very-low-carbohydrate diet produced additional effects on lipid metabolism. This occurred specifically within a population managing obesity, prediabetes, and fatty liver disease. These findings are clinically interesting but require careful interpretation by medical professionals.
The ketogenic intervention yielded notably different outcomes for daily glucose and insulin measurements. Twenty-four-hour blood-glucose measurements fell by 20 percent from baseline in the ketogenic group. The Mediterranean and plant-forward groups both recorded an 8 percent decrease. These metrics highlight how specific macronutrient choices affect daily glucose regulation.
Average all-day insulin levels showed similarly divergent responses across the groups. These hormonal levels declined by 74 percent with the ketogenic diet. The Mediterranean diet produced a 44 percent drop during the same timeframe. Finally, the plant-forward diet yielded a 27 percent decrease in daily insulin.
The WashU researchers reported compelling shifts in diagnostic criteria by the end of the trial. Half of the ketogenic-diet participants no longer met the study’s criteria for prediabetes. Meanwhile, 29 percent of the Mediterranean group no longer met the criteria. Only 7 percent of the plant-forward group reached this same metabolic milestone.
The new findings offer valuable insights but do not erase existing clinical frameworks. Current MASLD guidance continues to emphasize sustained weight reduction and regular physical activity. Managing cardiometabolic risk factors like diabetes, blood pressure, sleep apnea, and lipids remains essential. Patients with poorly controlled hypertension or hyperglycemia may need disease-specific treatments alongside general weight-management efforts.
Established clinical frameworks link specific weight-loss thresholds to corresponding liver health benefits. At least 5 percent sustained weight loss is associated with reduced liver fat. Reaching a 7 to 10 percent reduction correlates with measurable improvement in liver inflammation. Achieving at least 10 percent weight reduction is associated with potential improvement in fibrosis.
Physical activity remains a cornerstone of metabolic care regardless of your dietary preference. Current guidance recommends more than 150 minutes per week of moderate-intensity activity. Alternatively, patients can aim for 75 minutes per week of vigorous activity. Exercise can reduce liver steatosis even without massive subsequent changes in body mass.
The WashU trial tested macronutrient composition while holding weight loss roughly constant. This specific clinical design answers a much narrower question than most real-world diet studies. Real-world applications often involve plans that produce vastly different rates of adherence over time. Success ultimately depends on aligning nutrition, habits, and movement within your actual lifestyle constraints.
Future clinical trials must determine how these specific diets perform in less controlled everyday environments. We need to see if the pronounced liver-fat differences persist over several years. The five-month duration leaves important questions about long-term sustainability entirely unanswered. Furthermore, researchers must evaluate these outcomes in broader populations without existing fatty liver disease.
Medical professionals need long-term maintenance data and broader safety outcomes before updating standard care protocols. The reported results do not justify abandoning prescribed cardiometabolic medications or established medical therapies. Achieving a 10 percent reduction in body weight provides substantial health benefits regardless of the exact method chosen. We will continue to monitor future studies to see how these nutritional strategies perform in ordinary, unsupervised settings.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
